Table 2.
Univariate and multivariate analysis for risk of hospitalization among BA.4 and BA.5 cases.
Univariate analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
RR | 95% CI | p–value | aRR | 95% CI | p–value | |
Sex | ||||||
Males | ref | ref | ||||
Females | 1.45 | [0.43–4.93] | NS | 1.30 | [0.34–5.30] | NS |
Age | ||||||
Under 70 | ref | ref | ||||
70 and over | 12.96 | [3.59–46.74] | <0.001 | 3.33 | [0.84–14.60] | NS |
Risk factors a | ||||||
No | ref | ref | ||||
Yes | 30.44 | [3.83–242.16] | <0.001 | 16.72 | [2.59–326.86] | <0.05 |
Vaccination status b | ||||||
1 dose or less | ref | |||||
2 doses or more | 0.47 | [0.13–1.65] | NS | 2.89 | [0.61–11.08] | NS |
Travel | ||||||
No | ref | |||||
Yes | 0.50 | [0.11–2.33] | NS | |||
Cluster | ||||||
No | ref | |||||
Yes | 2.50 | [0.65–9.61] | NS |
RR, risk ratio; CI, confidence interval; aRR, adjusted risk ratio; ref, reference category; NS, not significant.
Risk factors include hypertension, diabetes, heart disease, kidney disease, respiratory illness, immunosuppression, obesity, cancer, neuromuscular disease, and/or pregnancy.
A previous infection was considered as a dose.